Clinical Trial 48460

Dallas, TX 75231


The purpose of this clinical research study is to learn more about the use of the study drug, IMC-1, for the potential treatment of fibromyalgia. IMC-1 is somewhat different from other investigational drugs in that it is a combination of two drugs that already have FDA approval for the treatment of other conditions, but not for fibromyalgia. The main purpose of this study is to see whether IMC-1 can help participants with fibromyalgia. 

Qualified Participants Must:

• Participants must be between the ages of 18 and 65 and experiencing symptoms of fibromyalgia

Qualified Participants May Receive:

If you qualify, you may receive investigational medication and study-related procedures from a local doctor. Reimbursement for time and travel related to study participation may be provided.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.